Latest news
FDA Approves Moderna's mRNA-Based Flu Vaccine - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 13:07:44 GMTConsistent Safety Profile of Risankizumab Across Psoriasis and Psoriatic Arthritis - HCPLiveHCPLive · Thu, 06 Aug 2026 12:05:44 GMTClearmind's CMND-100 trial reaches 160 mg with no serious adverse events - Stock TitanStock Titan · Thu, 30 Jul 2026 12:30:00 GMT